Published in Retrovirology on February 19, 2010
Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort. Viruses (2011) 0.87
Retroviral DNA-the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats. Retrovirology (2015) 0.79
GAPDH Pseudogenes and the Quantification of Feline Genomic DNA Equivalents. Mol Biol Int (2013) 0.78
Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study. BMC Vet Res (2015) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform (2008) 24.69
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus. J Virol (1983) 2.24
Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection. Vet Immunol Immunopathol (1995) 2.21
Selection forces and constraints on retroviral sequence variation. Science (2001) 2.17
Acquired immunodeficiency syndrome-related lymphoma. Blood (1992) 1.97
Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature (1988) 1.94
Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods (1983) 1.94
A VIRUS-LIKE PARTICLE ASSOCIATED WITH LEUKEMIA (LYMPHOSARCOMA). Nature (1964) 1.60
Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol (1999) 1.49
AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol (1991) 1.45
Feline leukemia virus infection and diseases. J Am Vet Med Assoc (1991) 1.37
Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J Virol Methods (1999) 1.36
Excretion of feline leukaemia virus by naturally infected pet cats. Nature (1977) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol (1991) 1.32
Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J Virol (1993) 1.28
Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. J Virol Methods (2005) 1.26
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol (1990) 1.17
Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol (2001) 1.14
Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12
Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine (2005) 1.09
Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology (1992) 1.06
Re-examination of feline leukemia virus: host relationships using real-time PCR. Virology (2005) 1.05
Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol (1990) 1.04
Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection. AIDS Res Hum Retroviruses (2002) 1.04
Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol (2005) 1.04
Reactivation of latent feline leukaemia virus infection. Nature (1982) 1.00
Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol (1997) 1.00
Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues. BMC Mol Biol (2009) 1.00
Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol (2005) 0.98
Molecular cloning of a feline leukemia provirus integrated adjacent to the c-myc gene in a feline T-cell leukemia cell line and the unique structure of its long terminal repeat. Virology (1989) 0.98
Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol (1996) 0.98
Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr (1990) 0.97
Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up. Vaccine (2006) 0.97
Pathogenicity of feline leukemia virus is commonly associated with variant viruses. Leukemia (1992) 0.92
Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc Natl Acad Sci U S A (2007) 0.91
Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor. Proc Natl Acad Sci U S A (2009) 0.91
Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A. J Virol (2000) 0.90
Rapid detection of feline leukemia virus provirus integration into feline genomic DNA. Mol Cell Probes (2006) 0.89
Transmission of feline leukaemia virus in the milk of a non-viraemic cat. Vet Rec (1986) 0.89
How molecular methods change our views of FeLV infection and vaccination. Vet Immunol Immunopathol (2008) 0.88
Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J Virol (2002) 0.87
Feline leukemia virus and feline immunodeficiency virus infections in a cat with lymphoma. J Am Vet Med Assoc (1989) 0.87
The C domain in the surface envelope glycoprotein of subgroup C feline leukemia virus is a second receptor-binding domain. Virology (2007) 0.86
Characterization of feline T cell receptor gamma (TCRG) variable region genes for the molecular diagnosis of feline intestinal T cell lymphoma. Vet Immunol Immunopathol (2005) 0.86
Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine. J Am Vet Med Assoc (1991) 0.86
Identification of monoclonal antibodies for immunohistochemical staining of feline B lymphocytes in frozen and formalin-fixed paraffin-embedded tissues. Can J Vet Res (1996) 0.85
Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries. J Virol (2005) 0.85
Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays. Vet Immunol Immunopathol (2008) 0.85
Recovery of feline leukaemia virus from non-viraemic cats. Vet Rec (1983) 0.84
Structure and function of the long terminal repeats of feline leukemia viruses derived from naturally occurring acute myeloid leukemias in cats. J Virol (1997) 0.84
Serological diagnosis of feline immunodeficiency virus infection using recombinant transmembrane glycoprotein. Vet Immunol Immunopathol (1995) 0.84
Absolute quantitation of feline leukemia virus proviral DNA and viral RNA loads by TaqMan real-time PCR and RT-PCR. Methods Mol Biol (2008) 0.84
Advances in understanding molecular determinants in FeLV pathology. Vet Immunol Immunopathol (2008) 0.83
Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants. Virology (1994) 0.82
The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome. Vet Microbiol (2008) 0.81
Frequency and significance of feline leukemia virus infection in necropsied cats. Am J Vet Res (1987) 0.81
Duration of the latent state in feline leukaemia virus infections. Vet Rec (1985) 0.81
Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Vet Immunol Immunopathol (1998) 0.80
Atypical localised viral expression in a cat with feline leukaemia. Vet Rec (1989) 0.79
Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases. Vet Microbiol (1996) 0.79
Malignant lymphoma associated with experimentally induced feline immunodeficiency virus infection. J Comp Pathol (1994) 0.79
Expression of viral proteins in feline leukemia virus-associated enteritis. Vet Pathol (2000) 0.78
Characterization of feline immunoglobulin heavy chain variable region genes for the molecular diagnosis of B-cell neoplasia. Vet Pathol (2005) 0.77
Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age. Can J Vet Res (1996) 0.77
Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation? J Virol (1998) 0.77
Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust Vet J (2001) 0.77
[Quantification of proviral FIV DNA using competitive PCR]. Schweiz Arch Tierheilkd (1996) 0.76
A new subgroup of immunoglobulin heavy chain variable region genes for the assessment of clonality in feline B-cell lymphomas. Vet Immunol Immunopathol (2009) 0.75
Identification, molecular characterization, and experimental transmission of a new hemoplasma isolate from a cat with hemolytic anemia in Switzerland. J Clin Microbiol (2005) 1.87
Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. J Clin Microbiol (2005) 1.84
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol (2006) 1.84
Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques. AIDS (2002) 1.69
Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J Clin Microbiol (2006) 1.63
SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development (2010) 1.61
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. AIDS (2003) 1.55
Toxoplasma gondii infection in cats: ABCD guidelines on prevention and management. J Feline Med Surg (2013) 1.52
Comparison of different tests to diagnose feline infectious peritonitis. J Vet Intern Med (2003) 1.49
Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood (2009) 1.46
2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J Feline Med Surg (2008) 1.43
Prevention of infectious diseases in cat shelters: ABCD guidelines. J Feline Med Surg (2013) 1.42
Description of outcomes of experimental infection with feline haemoplasmas: copy numbers, haematology, Coombs' testing and blood glucose concentrations. Vet Microbiol (2009) 1.38
Selfish supernumerary chromosome reveals its origin as a mosaic of host genome and organellar sequences. Proc Natl Acad Sci U S A (2012) 1.37
From RNA-seq to large-scale genotyping - genomics resources for rye (Secale cereale L.). BMC Plant Biol (2011) 1.35
Intraspecific variation of recombination rate in maize. Genome Biol (2013) 1.32
Phylogenetic analysis of "Candidatus Mycoplasma turicensis" isolates from pet cats in the United Kingdom, Australia, and South Africa, with analysis of risk factors for infection. J Clin Microbiol (2006) 1.29
The prevalence of three species of feline haemoplasmas in samples submitted to a diagnostics service as determined by three novel real-time duplex PCR assays. Vet Microbiol (2007) 1.27
Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. J Virol Methods (2005) 1.26
Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood (2003) 1.22
Real-time PCR investigation of potential vectors, reservoirs, and shedding patterns of feline hemotropic mycoplasmas. Appl Environ Microbiol (2007) 1.15
Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol (2005) 1.15
Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol (2002) 1.15
Genetic architecture of complex agronomic traits examined in two testcross populations of rye (Secale cereale L.). BMC Genomics (2012) 1.15
From Haemobartonella to hemoplasma: molecular methods provide new insights. Vet Microbiol (2007) 1.14
Birds as potential reservoirs of tick-borne pathogens: first evidence of bacteraemia with Rickettsia helvetica. Parasit Vectors (2014) 1.14
Development and application of a universal Hemoplasma screening assay based on the SYBR green PCR principle. J Clin Microbiol (2009) 1.13
Worldwide occurrence of feline hemoplasma infections in wild felid species. J Clin Microbiol (2007) 1.13
Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12
Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg (2009) 1.12
Molecular Investigations of Rickettsia helvetica infection in dogs, foxes, humans, and Ixodes ticks. Appl Environ Microbiol (2009) 1.11
Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV. Vaccine (2002) 1.11
Real-time PCR-based prevalence study, infection follow-up and molecular characterization of canine hemotropic mycoplasmas. Vet Microbiol (2007) 1.09
Prevalence and geographical distribution of canine hemotropic mycoplasma infections in Mediterranean countries and analysis of risk factors for infection. Vet Microbiol (2009) 1.09
Identification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus). J Virol (2002) 1.09
RNase P RNA gene (rnpB) phylogeny of Hemoplasmas and other Mycoplasma species. J Clin Microbiol (2008) 1.09
Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine (2005) 1.09
Detection of colostrum-derived alloantibodies in calves with bovine neonatal pancytopenia. Vet Immunol Immunopathol (2011) 1.09
Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland. J Clin Microbiol (2004) 1.09
Molecular investigation of hard ticks (Acari: Ixodidae) and fleas (Siphonaptera: Pulicidae) as potential vectors of rickettsial and mycoplasmal agents. Vet Microbiol (2009) 1.08
Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter. Matrix Biol (2008) 1.08
Distribution of Mycoplasma haemofelis in blood and tissues following experimental infection. Microb Pathog (2009) 1.08
Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur J Immunol (2008) 1.07
Clinical, laboratory and pathological findings in dogs experimentally infected with Angiostrongylus vasorum. Parasitol Res (2010) 1.06
Genetic diversity of anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development. Anim Health Res Rev (2005) 1.06
In vivo transmission studies of 'Candidatus Mycoplasma turicensis' in the domestic cat. Vet Res (2009) 1.05
Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood (2007) 1.05
Feline immunodeficiency. ABCD guidelines on prevention and management. J Feline Med Surg (2009) 1.05
Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa. J Virol (2004) 1.03
Feline calicivirus infection. ABCD guidelines on prevention and management. J Feline Med Surg (2009) 1.03
Sites of feline coronavirus persistence in healthy cats. J Gen Virol (2010) 1.02
Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res (2006) 1.01
Seroprevalences to viral pathogens in free-ranging and captive cheetahs (Acinonyx jubatus) on Namibian Farmland. Clin Vaccine Immunol (2009) 1.00
Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues. BMC Mol Biol (2009) 1.00
Reticulate evolution of the rye genome. Plant Cell (2013) 1.00
Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun (2007) 0.99
Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg (2009) 0.98
Genome sequence for "Candidatus Mycoplasma haemominutum," a low-pathogenicity hemoplasma species. J Bacteriol (2012) 0.97
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. Virology (2006) 0.97